National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$48.75
add to cart

Rights & Permissions

topleft topright

Immunization Safety Review: Multiple Immunizations and Immune Dysfunction (2002)
Institute of Medicine (IOM)

Citation Manager

. "Scientific Assessment." Immunization Safety Review: Multiple Immunizations and Immune Dysfunction. Washington, DC: The National Academies Press, 2002.

Please select a format:

BibTeX EndNote RefMan


Page
72
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Immunization Safety Review: Multiple Immunizations and Immune Dysfunction

TABLE 4 Evidence Table: Controlled Epidemiological Studies—Vaccines and Allergic Disorders

Citation

Design

Population

Vaccines

Outcome Measures

Results

Comment

Contribution to Causality Argument

Wickens et al. (2001)

Case- control

233 cases with wheezing or asthma; 241 controls; ages 7–9 years (New Zealand)

DTP,* DT, polio, MMR, measles, BCG, HepB from medical records

Wheezing or asthma in last 12 months by proxy or self-report

Unadjusted ORs (95% CI):

DTP = 1.51 (0.77-2.97)

DT/DTP = 1.43 (0.69-2.96)

HepB = 0.72 (0.50-1.06)

Polio = 2.11 (0.90-4.90)

Measles/MMR = 1.52 (0.89-2.58)

MMR = 1.62 (1.06-2.47)

BCG = 1.23 (0.41-3.72)

Adjusted ORs (95% CI)

HepB = 0.66 (0.42-1.05)

Polio = 2.48 (0.83-7.41)

MMR = 1.43 (0.85-2.41)

Potential selection bias, exposure misclassification, or multiple comparisons

weak evidence relevant to causality; favors no effect of any vaccine

Hurwitz & Morgenstern (2000)

cross-sectional survey (NHAN ES III)

13,944 infants and children ages 2 months through 16 years (United States)

DTP* or tetanus, by proxy (information obtained from children’s parent or guardian)

history of physician-diagnosed asthma, hay fever; self-report of allergic reactions by proxy; atopy by skin testing with 10 allergens

Estimated Crude ORs (95% CI)/Adjusted ORs (95% CI) of DTP or tetanus vaccination on following

Asthma = 2.20 (0.70-6.84)/2.00 (0.59-6.74)

Hay fever = 1.21 (0.21-6.83)/ 0.82 (0.16-4.35)

Severe allergic reaction = 2.11 (9.42-10.45)/1.50 (0.33-6.89)

Any allergy/allergic reaction = 2.11 (0.81-5.49)/1.66 (0.67-4.14)

Sinusitis/sinus problems = 2.16 (0.77-6.06)/1.81 (0.69-4.71)

Wheezing/whistling = 1.03 (0.68- 1.57)/1.23 (0.78?1.95)

Nose & eye symptoms = 2.44

Study limitations included the following: cross-sectional design, recall bias; missing data on 2.4% of unvaccinated subjects; small number of unvaccinated children; lack of clinical information; selection bias for care-seeking behavior; unmeasured confounding; limited ability to control for con

weak evidence relevant to causality; favors effect of DTP or tetanus vaccine on clinical history of allergic disorder but no effect on atopy defined by skin test reactivity

Page
72